Abstract
Assisted reproductive technology in PCOS patients is often associated with ovarian hyperstimulation syndrome (OHSS). The severe form of OHSS is an iatrogenic complication and possibly a life-threatening condition resulting from ovarian stimulation. In vitro maturation (IVM) techniques have been developed and employed in clinical settings to circumvent OHSS by minimizing or eliminating gonadotropin administration. The aim of this study was to assess the efficacy of IVM in PCOS patients by comparing its clinical outcome with that of conventional ovarian stimulation protocols.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
